Fig. 4From: The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degenerationBox plot showing the best-corrected visual acuity measured in the number of ETDRS letters (A) and central retinal thickness (B) measured over time. White boxes represent data from the standard care (SC) treatment regimen with grey boxes representing data from the treat-and-extend (T&E) treatment regimen. For all box plots, the horizontal black line denotes the median value with the 25th and 7th percentiles. Error bars represent the minimum and maximum valuesBack to article page